News Archive

July 2021

CEVEC Pharmaceuticals GmbH (CEVEC), the leading provider of high-performance cell technology for scalable manufacturing of advanced bio-therapeutics, today announced the successful closing of an internal growth financing round.

Congratulations to our portfolio company Emperra GmbH E-Health Technologies for the listing of their ESYSTA App as the first Diabetes DiGA and becoming the first broadly reimbursed digital diabetes solution in Germany. This is a major achievement and will help many diabetic patients in their daily life.